Rigel Pharmaceuticals, Inc. (RIGL)
34.21
-0.53
(-1.53%)
USD |
NASDAQ |
Mar 02, 11:19
Rigel Pharmaceuticals Research and Development Expense (Annual) : 23.38M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Nektar Therapeutics | 119.64M |
| Eli Lilly & Co. | 13.34B |
| Ironwood Pharmaceuticals, Inc. | 93.26M |
| BioMarin Pharmaceutical, Inc. | 700.97M |
| Catalyst Pharmaceuticals, Inc. | 12.71M |